Resources from the same session
Present standard of care according to the 2019 ESMO Guidelines
Presenter: Manuela Schmidinger
Session: ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting?
Resources:
Slides
Webcast
Comparative outcome in 1st line according to prognostic group and criteria for decision making
Presenter: Camillo Guglielmo Porta
Session: ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting?
Resources:
Slides
Webcast
Options and criteria for treatment choice in 2nd and 3rd lines
Presenter: Ronald de Wit
Session: ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting?
Resources:
Slides
Webcast
How to the sequence the use of drugs in a multi-lines’ strategy for RCC?
Presenter: Bernard Escudier
Session: ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting?
Resources:
Slides
Webcast